Literature DB >> 6972294

Effect of prostaglandin E2 on gastric mucosal bleeding caused by aspirin.

J N Hunt, D R Franz.   

Abstract

The effect of prostaglandin E2 on gastric mucosal bleeding caused by aspirin was studied. Blood in serial gastric washings was measured chemically for 30 min. Normal blood loss was equivalent to 0.05 ml/day. Aspirin, 600 mg four times daily, increased gastric bleeding on day 1; bleeding was further increased on day 2. On day 2, ingestion of 0.5 mg of prostaglandin E2 15 min before 600 mg of aspirin reduced the gastric microbleeding caused by aspirin. Prostaglandin E2, 0.5 mg four times daily, did not change the normal blood loss. No consistent changes in gastric emptying or in secretion of chloride were detected.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6972294     DOI: 10.1007/BF01308369

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  10 in total

1.  Stimulation by intragastrically administered E2 prostaglandins of human gastric mucus output.

Authors:  C Johansson; B Kollberg
Journal:  Eur J Clin Invest       Date:  1979-06       Impact factor: 4.686

2.  A sensitive method for measuring haemoglobin in gastric contents.

Authors:  M A Fisher; J N Hunt
Journal:  Digestion       Date:  1976       Impact factor: 3.216

3.  The inorganic components of gastric secretion.

Authors:  R B Fisher; J N Hunt
Journal:  J Physiol       Date:  1950-04-15       Impact factor: 5.182

4.  A procedure for measuring gastric bleeding caused by drugs.

Authors:  J N Hunt
Journal:  Dig Dis Sci       Date:  1979-07       Impact factor: 3.199

5.  Protection of gastric mucosa by prostaglandins.

Authors:  M I Grossman
Journal:  Gastroenterology       Date:  1979-09       Impact factor: 22.682

6.  Mucosal cytoprotection by prostaglandin E2.

Authors:  M M Cohen
Journal:  Lancet       Date:  1978-12-09       Impact factor: 79.321

7.  Effects of antiinflammatory agents and prostaglandins on acid and bicarbonate secretions in the amphibian-isolated gastric mucosa.

Authors:  A Garner; G Flemström; J R Heylings
Journal:  Gastroenterology       Date:  1979-09       Impact factor: 22.682

8.  Cytoprotection by prostaglandins in rats. Prevention of gastric necrosis produced by alcohol, HCl, NaOH, hypertonic NaCl, and thermal injury.

Authors:  A Robert; J E Nezamis; C Lancaster; A J Hanchar
Journal:  Gastroenterology       Date:  1979-09       Impact factor: 22.682

9.  Effect of orally administered prostaglandin E 2 and its 15-methyl analogues on gastric secretion.

Authors:  S M Karim; D C Carter; D Bhana; P A Ganesan
Journal:  Br Med J       Date:  1973-01-20

10.  Protective effect of prostaglandin E2 in the gastrointestinal tract during indomethacin treatment of rheumatic diseases.

Authors:  C Johansson; B Kollberg; R Nordemar; K Samuelson; S Bergström
Journal:  Gastroenterology       Date:  1980-03       Impact factor: 22.682

  10 in total
  9 in total

1.  A double-blind study of prophylactic effect of misoprostol on lesions of gastric and duodenal mucosa induced by oral administration of tolmetin in healthy subjects.

Authors:  F L Lanza
Journal:  Dig Dis Sci       Date:  1986-02       Impact factor: 3.199

Review 2.  Non-steroidal anti-inflammatory agents and the gastrointestinal tract.

Authors:  K W Somerville; C J Hawkey
Journal:  Postgrad Med J       Date:  1986-01       Impact factor: 2.401

3.  Gastric bleeding and gastric secretion with sulindac and naproxen.

Authors:  J N Hunt; J L Smith; C L Jiang
Journal:  Dig Dis Sci       Date:  1983-02       Impact factor: 3.199

4.  Oral antisecretory activity of prostaglandin E2 in man.

Authors:  S B Reele; D Bohan
Journal:  Dig Dis Sci       Date:  1984-05       Impact factor: 3.199

5.  Enhanced gastric mucosal bleeding with doses of aspirin used for prophylaxis and its reduction by ranitidine.

Authors:  G K Kitchingman; P J Prichard; T K Daneshmend; R P Walt; C J Hawkey
Journal:  Br J Clin Pharmacol       Date:  1989-11       Impact factor: 4.335

6.  Prostaglandins in peptic ulcer disease. An overview of current status and future directions.

Authors:  S J Sontag
Journal:  Drugs       Date:  1986-11       Impact factor: 9.546

7.  Treatment of nonsteroidal antiinflammatory drug-induced gastric ulcers with misoprostol. A double-blind multicenter study.

Authors:  R Jaszewski; D Y Graham; S C Stromatt
Journal:  Dig Dis Sci       Date:  1992-12       Impact factor: 3.199

8.  Effect of synthetic prostaglandin E1 analog on aspirin-induced gastric bleeding and secretion.

Authors:  J N Hunt; J L Smith; C L Jiang; L Kessler
Journal:  Dig Dis Sci       Date:  1983-10       Impact factor: 3.199

9.  Reduction of aspirin-induced fecal blood loss with low-dose misoprostol tablets in man.

Authors:  M M Cohen; L Clark; L Armstrong; J D'Souza
Journal:  Dig Dis Sci       Date:  1985-07       Impact factor: 3.199

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.